Axis Healthcare

Axis Healthcare offers Spravato at its Bixby, Oklahoma location for adults with treatment-resistant depression. The FDA-approved esketamine nasal spray is administered in a controlled clinical setting and used alongside oral antidepressants for patients who have not found relief with traditional medications.

Treatment begins with an initial consultation to review medical history and confirm eligibility. Patients self-administer the spray under supervision, with each session lasting about two hours of monitoring, and arrange transportation since driving is not permitted for 24 hours afterward.

The standard plan starts with two sessions per week for the first month, then tapers based on progress. Axis Healthcare provides ongoing follow-up, emotional support, and personalized guidance throughout treatment as part of a broader behavioral health practice.